Announced Fri, 17 Jul · 17:36 IST
Board to consider Q1 FY27 unaudited financial results on July 31, 2026
Results View source PDF
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹2060.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.4-1.1-1.5+2.2+1.9—————
Up moveDown movePending
AI summary
Corona Remedies board will meet on July 31, 2026 to consider and approve unaudited financial results (standalone and consolidated) for the first quarter ended June 30, 2026. Trading window for insiders remains closed till August 2, 2026.
Likely market impact
Q1 FY27 results expected after July 31 meeting. Watch for revenue, profit, and margin trends.